A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer
Status:
RECRUITING
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
This is a prospective, open, single-arm, investigator-initiated clinical study to evaluate the safety and efficacy of intravenous administration of T3011 at different doses in combination with oral regorafenib in the treatment of advanced colorectal cancer.